spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

CPhI Worldwide to support International Medical Corps UK with global charity partnership

CphI Worldwide 2017

Collaboration to help raise funds, awareness and engagement from pharma community for the charity’s lifesaving work in crises across the globe

Amsterdam, 4th October 2017: CPhI Worldwide, organised by UBM, announces a new dedicated charity partnership with International Medical Corps UK. The collaboration will see UBM extensively promote International Medical Corps across the global pharma community, with a range of fundraising and customised sponsorship packages.

International Medical Corps UK was selected in light of its vital work in delivering lifesaving healthcare and medicine on the frontlines of conflicts, natural disasters, famines and disease outbreaks. Spanning more than 25 countries, their work includes providing vital aid and supplies in hotspots such as Syria, South Sudan, Yemen and Afghanistan.

The charity specialises in delivering rapid support in crisis settings, often within just a few hours, and go where the needs are greatest. Donations will support worldwide relief, recovery and development projects such as midwifery training, emergency nutrition, clean water, improved sanitation and vaccination campaigns. They also enable International Medical Corps’ wider training efforts to equip local people with the knowledge and skills to be their own best First Responders.

UBM is supporting the charity by encouraging its enormous 100,000+ database to provide sponsorships via a variety of available charity packages and direct donations. Donations can be of any monetary value or in-kind while the charity packages range from €995 to €3995, with 100% of the sponsorship going directly to International Medical Corps.

To further incentivise the pharma industry, CPhI Worldwide will also provide a range of free advertising and promotion opportunities at the annual exhibition – the world’s largest pharma event – with a captive audience of more than 42,000 pharmaceutical professionals and industry press. CPhI will also facilitate pharma companies in the donation and distribution of vital medicines and vaccinations.

Rhylie Luanweir, Senior Group Marketing Manager at UBM EMEA commented: “This year we have partnered with International Medical Corps UK due to the outstanding work they carry out, from providing materials for sanitation and hygiene to emergency nutrition, on an international scale. More specifically, they provide their services in regions where people have very limited or no access to healthcare and medicine and in extremely challenging emergency situations. Their commitment and bravery is beyond reproach. CPhI Worldwide is a great platform to raise awareness of these communities in need, and motivate the pharma industry to incorporate charity giving into their business by simplifying the process. Businesses can extend their support in the form of purchasing packages, donating medicine or direct donations.”

“UBM’s long-standing commitment to the humanitarian sector makes them an ideal partner, and we’re thrilled to be working together. International Medical Corps have been given a fantastic opportunity to share our experiences with an industry integral to our work. The support of businesses, individuals and organisations like UBM is absolutely essential in order for us to continue to deliver life-saving care to the people who need it the most”
, added Kevin Noone, Executive Director, International Medical Corps UK.

To find how you or your business can help support this charity or to donate to International Medical Corps, please visit https://www.cphi.com/charity-and-sustainability.
email cphi@ubm.com
email Frankfurt, Germany
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Charles River Laboratories Makes Investments in High-Throughput Screening Infrastructure

WILMINGTON, Mass.--(BUSINESS WIRE)--Feb. 1, 2018-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced a new agreement which grants Charles River commercial access to AstraZeneca’s (NYSE: AZN) high-throughput screening (HTS) and compound management infrastructure. Through the agreement, Charles River will perform HTS programs for its clients utilizing AstraZeneca’s state-of-the-art HTS facility.
More info >>


White Papers

Points to Consider When Developing a TMF (Trial Master File) Strategy

Phlexglobal Ltd

Many organizations are currently outsourcing clinical trial activities to one or more contract research organizations (CROs). This strategy enables companies to leverage specialized expertise and take advantage of flexible resourcing throughout the conduct of a clinical trial. Outsourcing minimizes the costs of recruiting experts, building a team and maintaining an infrastructure. However, it can also add complexity as the organization looks to meets its compliance obligations regarding clinical trial documentation. The documentation referred to in Article 15(5) of Directive 2001/20/EC as the trial master file shall consist of essential documents, which enable both the conduct of a clinical trial and the quality of the data produced to be evaluated.1 This essential study specific documentation is also known as the TMF. As organizations try to minimize their reliance on paper files, the electronic TMF (eTMF) has emerged. A current industry initiative to standardize the organization of this content is known as the TMF Reference Model. This model is helping standardization efforts across paper and electronic systems. As companies implement outsourcing strategies, CROs and sponsor organizations look for a common foundation on which to build their TMF capabilities. The following paper outlines some of the challenges organizations face when outsourcing clinical trial activities to multiple contract research organizations and a strategy to facilitate partnering and management of trial information between sponsors and CROs.
More info >>

Industry Events

ASPIRE: International EDGE Conference

28 February - 1 March 2018, The Vox Conference Centre, Birmingham

The ASPIRE international conference is taking place on the 28th February and 1st March 2018 at the Vox Conference Centre in Birmingham. The conference brings together members of the research community including research professionals from the NHS, Clinical Trial Networks and international organisations. The ASPIRE conference will allow delegates to share knowledge and best practise with the focus on enhancing the efficiency and productivity of clinical research across the UK and beyond.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement